Agents for the treatment of retroviral infectious diseases
AssigneeImmunologik GmbH
InventorsUlrich Schubert, Christian Setz, Wolfgang Brysch, Jörg Von Wegerer
Life of this patent
Estimating the term…
Abstract
The invention relates to pyridine-3,5-bis-thiocyanates which are new active substances for the treatment and prevention of retroviral infections and secondary diseases thereof, in particular HIV infections and AIDS, from the group of deubiquitinase inhibitors. Administration of the compounds of the invention increases the immunogenicity of viral proteins and thus the antiviral response.
Claims3
A method of treating an individual having an HIV-1 infection, by administering to such individual a pharmaceutically effective amount of 2,6-diaminopyridine-3,5-bis(thiocyanate) or its pharmaceutically acceptable salts, hydrates and solvates.
Dependencies are inferred from the claim text.